Medtronic Set to Highlight Innovations at Upcoming Investor Conferences

Medtronic to Showcase Leadership at Upcoming Investor Conferences

Galway, Ireland - Medtronic plc, a prominent player in the global healthcare technology sector, prepares for two significant investor conferences this month, featuring Thierry Piéton, the company's Executive Vice President and Chief Financial Officer. Piéton is scheduled to speak at the Barclays 28th Annual Global Healthcare Conference on March 10, 2026, at 10:30 a.m. EST, followed by an appearance at the Leerink Partners Global Healthcare Conference on March 11, 2026, at 9:20 a.m. EST. Both events will have live webcasts available through Medtronic's investor relations webpage, with archived sessions accessible later in the day.

These conferences present an opportunity for Medtronic to reinforce its commitment to tackling major health challenges worldwide. The company employs over 95,000 individuals across more than 150 countries, aiming to alleviate pain, restore health, and extend lives. Medtronic is known for its innovative solutions across various health conditions, including cardiac devices, surgical robotics, and insulin pumps, which are integral to its mission of engineering extraordinary outcomes. By transforming the lives of approximately two individuals every second, Medtronic continues to emphasize patient experience through insight-driven technology.

As Medtronic prepares for these conferences, the focus remains not only on showcasing financial leadership but also on illustrating how its emerging technologies and healthcare solutions can address pressing global health issues. The fireside chats, led by Piéton, serve as a platform for discussing strategic initiatives, innovations, and company directions that align with Medtronic's core values and mission. Stakeholders are encouraged to stay informed about any developments shared during these sessions, which can provide insights into the company's vision for the future of healthcare.

In addition to the upcoming conferences, Medtronic maintains a commitment to transparency regarding its future directions and potential risks associated with its operations. The company invites stakeholders to review its periodic reports filed with the Securities and Exchange Commission for a comprehensive understanding of these factors. For personalized inquiries, media representative Justin Paquette is reachable at +1-612-271-7935, and investor relations contact Ingrid Goldberg can be reached at +1-763-505-2696.